Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.44 |
| ▸ | AHR | P35869 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 3/20 | 0.41 |
| ▸ | TNKS | O95271 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.41 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24221745 | 0.94 | MAOB (0.43) | MAOBAHRMAOATNKSPARP1 | |
| SCHEMBL21315938 | 0.85 | MAOB (0.39) | MAOBMAPTHPGDMEN1KMT2A | |
| SCHEMBL25788154 | 0.85 | MAPT (0.46) | MAOBMAOATNKSPARP1TNKS2 | |
| SCHEMBL19011019 | 0.82 | CYP3A4 (0.41) | MAOBMAOATNKSPARP1TNKS2 | |
| SCHEMBL9917209 | 0.81 | MAOB (0.58) | MAOBAHRMAOATNKSPARP1 | |
| SCHEMBL9917159 | 0.81 | MAOB (0.58) | MAOBAHRMAOATNKSPARP1 | |
| SCHEMBL17523446 | 0.81 | MAOB (0.58) | MAOBAHRMAOATNKSPARP1 | |
| SCHEMBL24544696 | 0.81 | MAOB (0.41) | MAOBAHRMAOATNKSPARP1 | |
| SCHEMBL25775095 | 0.81 | ALDH1A1 (0.40) | MAOBMAOATNKSPARP1TNKS2 | |
| SCHEMBL30743074 | 0.81 | AHR (0.59) | MAOBAHRMAOATNKSPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11208368-B2 | Double-spiro type compound and organic light-emitting device containing same | LG CHEM, LTD. (KR) | 2021-12-28 | — | — | US | disclosed |
| US-11031560-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. (KR) | 2021-06-08 | — | — | US | disclosed |
| US-20190345082-A1 | DOUBLE-SPIRO TYPE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2019-11-14 | — | — | US | disclosed |
| US-20180138422-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11208368-B2 | Double-spiro type compound and organic light-emitting device containing same | NR2E3, CRY1, CRY2 | MAOB 3095/4885AHR 784/4885MAOA 3493/4885 |
| US-11031560-B2 | Compound and organic electronic element comprising same | OR10J3, ESR1, ETV6 | MAOB 1103/4885AHR 1945/4885MAOA 860/4885 |
| US-20190345082-A1 | DOUBLE-SPIRO TYPE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME | NR2E3, CRY1, CRY2 | MAOB 3095/4885AHR 784/4885MAOA 3493/4885 |
| US-20180138422-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ESR1, ETV6 | MAOB 1103/4885AHR 1945/4885MAOA 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.